EBM Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Min, J.-Y.
Right arrow Articles by Morgan, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Min, J.-Y.
Right arrow Articles by Morgan, J. P.
Experimental Biology and Medicine 227:632-638 (2002)
© 2002 Society for Experimental Biology and Medicine


ORIGINAL ARTICLE

Genistein Attenuates Postischemic Depressed Myocardial Function by Increasing Myofilament Ca2+ Sensitivity in Rat Myocardium1

Jiang-Yong Min, Haisun Liao, Ju-Feng Wang, Matthew F. Sullivan, Toshiro Ito and James P. Morgan,2

The Charles A. Dana Research Institute and the Harvard-Thorndike Laboratory, Cardiovascular Division, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02215


    Abstract
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
The present study investigated whether genistein, a broad-spectrum tyrosine kinase inhibitor, could increase the myofilament Ca2+ sensitivity and partially reverse postischemic depressed myocardial function. Left ventricular papillary muscles were isolated from adult Wistar rats and loaded with the Ca2+ indicator, aequorin. The use of fluorocarbon immersion with hypoxia simulated a model of ischemia. Myofilament responsiveness to Ca2+ was evaluated from force-[Ca2+]i relationship recorded during tetani in papillary muscles. Protein levels of troponin I (TnI) were measured in postischemic papillary muscles with the Western blot technique. Isometric contraction was depressed during the period of ischemia and remained low after 60 min of reoxygenation without a corresponding significant change of peak [Ca2+]i in the control group (n = 7). In contrast, the depression of isometric contraction was ameliorated during ischemia in muscle preparations in the presence of genistein (2 µM; n = 8), and postischemic depressed myocardial contractility partially recovered after a 60-min reperfusion. The myofilament Ca2+ responsiveness was significantly increased in papillary muscles in the presence of genistein. Protein levels of TnI were reduced in postischemic papillary muscles, whereas genistein partially restored decreased protein levels of TnI. Our results reveal that genistein produces an effective attenuation of postischemic depressed myocardial function and improves myofibrillar Ca2+ responsiveness in rat myocardium.

Key Words: genistein • intracellular Ca2+ • ischemia • troponin I


    Introduction
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
It has been demonstrated that impaired intracellular Ca2+ ([Ca2+]i) modulation is one of the primary factors in the pathogenesis of postischemic myocardial stunning (13). Analysis of experimental models has localized the impairment of the contractile machinery to a reduction of myofilament Ca2+ responsiveness (1, 2, 4). A loss of TnI from the cell, the altered structure of TnI, and the altered function and interactions of TnI are the possible events in ischemia-reperfusion injury (5). Kusuoka and Marban (3) suggested that stunning is associated with a reversible breakdown and replacement of damaged myofilament proteins. Additionally, McDonough et al. (5) reported that altered thin-filament regulation with TnI degradation resulted in myocardial stunning and more severe episodes of ischemia with and without reperfusion. Huang et al. (6) showed diastolic dysfunction and reduced myofilament responsiveness to Ca2+ in TnI gene-ablated mouse hearts. We hypothesize that myocardial stunning might also be associated with phosphorylation of TnI in addition to proteolysis and degradation of TnI during the ischemia-reoxygenation cycle.

Activation of protein kinase C (PKC) and protein kinase A (PKA) by increased catecholamine levels during the ischemia-reperfusion cycle, via stimulation of the {alpha}-adrenoreceptor and ß-adrenoreceptor, respectively, leads to activation of the Raf-1 kinase/extracellular signal-regulated protein kinase (ERK) cascade (7, 8). This activation subsequently results in phosphorylation of TnI, decreased Ca2+ sensitivity, or decreased activity of actomyosin MgATPase and a decreased rate or affinity of Ca2+ binding to troponin C (TnC) (9, 10). It has been accepted that tyrosine kinases are responsible for activation of ERKs induced by isoproterenol in cardiac myocytes (11). Stimulation of tyrosine kinase by activated ERKs may contribute to the postischemic ventricular dysfunction via phosphorylation of TnI. Activation of ERKs by isoproterenol was suppressed completely when cardiomyocytes were pretreated with the broad-spectrum tyrosine kinase inhibitor, genistein (11). The aim of this study was to investigate whether genistein may partially reverse postischemic ventricular dysfunction by increasing the myofilament Ca2+ sensitivity resulting from inhibiting the activation of tyrosine kinase.


    Methods
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
The experiments were performed in male Wistar rats (Charles River Laboratories, Wilmington, MA) weighing 250–300 g. Animals were housed individually under climate-controlled conditions with a 12:12-hr light:dark cycle and free access to a standard rat chow and tap water ad libitum. The study was conducted under the guidelines for The Care and Use of Laboratory Animals published by the U.S National Institutes of Health (NIH Publication 85-23, revised 1996), and the experimental protocol was approved by the Institutional Animal Care and Use Committee at Beth Israel Deaconess Medical Center.

Isolated Muscle Performance.
The rats were sacrificed under deep pentobarbital anesthesia. Each heart was rapidly excised and placed in a dissecting chamber containing a modified Krebs-Henseleit solution of the following composition (in millimoles): NaCl 120, KCl 5.9, dextrose 5.5, NaHCO3 25, NaH2PO4 1.2, MgCl2 1.2, and CaCl2 1.0, pH 7.4, bubbled with carbogen (a mixture of 95% O2 and 5% CO2) at room temperature. A left ventricular posterior papillary muscle was carefully dissected and fixed to a muscle holder with a spring clip. The tendinous end of the muscle was vertically connected to a strain-gauge tension transducer (Model MBI 341; Sensotec, Columbus, OH) with a silk thread. The muscle was then mounted in a 50-ml tissue bath containing modified Krebs-Henseleit solution maintained at 30°C and continuously bubbled with carbogen. The isometric contraction of the papillary muscle was elicited by a punctate platinum electrode with square-wave pulses of 5 ms duration at 0.33 Hz. The voltage was set to 10% above threshold level. After a 30-min equilibration period, the muscle was carefully stretched to the length at which maximal tension developed. Developed tension (tension produced by the stimulated muscle) was recorded from each muscle at this maximal length. Subsequently, the loading procedure for aequorin was performed (see below).

Aequorin Light Signal Measurement.
Aequorin (Dr. John Blinks, Friday Harbor Laboratory, San Juan Island, WA) was loaded by the macroinjection technique (12). Briefly, the muscle preparation was raised from the organ bath and 1–2 µl of aequorin solution (2 mg/ml) was injected under the epimysium at the base of the muscle with a short-shank low-resistance glass micropipette. After an equilibrium period of 90–120 min, the stimulation was restarted at 0.33 Hz. The aequorin light signal was detected with a photomultiplier tube (PM28B; Thorn EMI Electron Tubes, Rockaway, NJ) and converted into a voltage signal. The analog signals from the isometric force transducer and electronic photometer were recorded with a chart-strip recorder (Model 56-1X 40-006158; Gould Instrument Systems, Cleveland, OH). To improve the signal-to-noise ratio, 64–128 steady-state light signals and isometric twitches were averaged with a digital oscilloscope (Model 4094; Nicolet Instrument, Madison, WI). The free intracellular concentration of calcium ([Ca2+]i) was estimated by normalizing the recorded light signal during the isometric twitch with the maximal amount of light emitted after lysis of the muscle membranes at the end of the experiment with a 5% solution of the detergent Triton X-100 in phosphate-free physiological salt solution containing 50 mM Ca2+. The normalized light signal was then converted to [Ca2+]i using an in vitro calibration curve as previously reported (2, 12).

Simulated-Ischemia Model with Fluorocarbon.
Steady-state conditions were observed for at least 30 min. After measuring the baseline parameters in physiological salt solution (PSS) with oxygenation (95% O2 and 5% CO2), isolated papillary muscles were exposed to oxygenated fluorocarbon (Fluorinert [FC-47]; 3M Co., St. Paul, MN) and were equilibrated for a 30-min period. After this, ischemia was induced by exposing muscle preparations to a 20-min period of hypoxia (95% N2 and 5% CO2) with fluorocarbon immersion. Subsequently, reoxygenation was repeated in rat muscles with fluorocarbon for 60 min. Failure of the developed tension to return to preischemic condition was taken as evidence of postischemic myocardial stunning.

Experimental Protocol.
Steady-state conditions were observed for at least 30 min after the intracellular aequorin light signal had stabilized. After measurement of all parameter baseline values and the values at fluorocarbon immersion, effective doses of genistein (2 µM) were added into the organ bath in the genistein-pretreated group (n = 8), whereas no drug was added in the control group (n = 7). Steady-state measurements of contractility and aequorin light signals were obtained 30 min after the addition of genistein. Subsequently, a simulated-ischemia model with fluorocarbon immersion was performed in all muscle preparations as mentioned above.

Steady-State Force-[Ca2+]i Relations.
Myofilament responsiveness to Ca2+ was evaluated by force-[Ca2+]i relationships recorded during tetanus (13). In the mammalian cardiac muscle, complete fusion of individual tetani can be accomplished by prior inhibition of sarcoplasmic reticulum function with ryanodine (14). After reoxygenation for 60 min in the fluorocarbon immersion, 0.2 µM ryanodine was added into the bath, which caused a reduction in isometric force and [Ca2+]i. Steady state was reached approximately 20 min after adding ryanodine in the condition of fluorocarbon immersion. Muscle tetanus was induced by stimulating the intact papillary muscle at 15 Hz for 5 s using stimulus pulses 50 ms in duration with field electrodes. Tetanus was elicited at varying extracellular Ca2+ concentrations of 1.0, 2.0, 4.0, 8.0, and 12.0 mM. Our preliminary experiments suggested that there was no further increase in tetanic force at higher extracellular Ca2+ levels above 8.0 mM. Phosphate was removed from the bath medium during these determinations to avoid Ca2+ precipitation. The muscle developed tension versus [Ca2+]i curves were fitted to the Hill equation:

where T is developed tension of the papillary muscle, Tmax is maximal developed tension, n is Hill coefficient, and [Ca2+]i50 is [Ca2+]i required for 50% activation.

Immunoblotting.
Total proteins (five for each) extracted from nonischemic and postischemic papillary muscles with or without pretreatment of genistein were analyzed for expression of TnI by immunoblotting. Briefly, muscle preparations were lysed in a lysis buffer (137 mM NaCl, 20 mM Tris-HCl, pH 7.4, 20 mM NaF, 1 mM Na-pyrophosphate, 1 mM vandate, 10% glycerol, 4 µg/ml leupeptin, 4 µg/ml pepstain, and 1 mM phenylmethylsulfonyl fluoride). The protein concentrations were determined by the Biaford method (Bio-Rad, Hercules, CA). Cell lyses containing 50 µg/lane proteins were separated by electrophoresis on 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) gels and were transferred onto a polyvinylidene difluoride membrane (Micron Separations, Westboro, MA). After transfer, the membrane was blocked in 5% fat-free milk in Tris-buffered saline/Tween 20, and was then probed by primary monoclonal antibodies to cardiac TnI (IgG2b, 41-SASRKLQLK-49; Research Diagnostics, Flanders, NJ). Bound primary antibody was detected using horseradish peroxidase-conjugated second antibody and was developed by an enhanced chemiluminescence Western blot kit (Amersham, Buckinghamshire, UK). All experiments were carried out three times, and cyclophilin A was employed as an internal control.

Statistical Analysis.
Data are expressed as mean ± SD. Baseline results were analyzed using Student’s t test for paired data. Intergroup comparisons were made with Student-Newman-Keuls multiple comparison tests. For ischemia-reoxygenation cycle studies, two-way analysis of variance (ANOVA) was used for intergroup comparisons. Significance was defined at the level of P < 0.05.


    Results
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
Effect of Genistein on Mechanical Function and Intracellular Ca2+.
Measurements of mechanical parameters and intracellular Ca2+ signals in rat papillary muscles are presented in Figure 1Go. Baseline developed tension was almost identical in all animals. After baseline measurement, papillary muscles were exposed to a 30-min period of fluorocarbon immersion bubbled with oxygen. No significant difference in isometric contractility or intracellular Ca2+ was found in either group with fluorocarbon (Fig. 1Go). Genistein (2 µM) was then added into the bath chamber and did not produce a significant change in either developed tension or [Ca2+]i.



View larger version (12K):
[in this window]
[in a new window]
 
Figure 1. Developed tension (A, percentage of baseline values) and peak systolic [Ca2+]i concentration (B, percentage of baseline values) in response to fluorocarbon simulated-ischemia model in papillary muscles isolated from adult rats. Control, rat papillary muscles without genistein (n = 7); Genistein, rat papillary muscles in the presence of genistein (2 µM; n = 8). PSS, values in the physiological salt solution with oxygenation; FC, values in the fluorocarbon immersion with oxygenation; Genistein, values in the presence of genistein (2 µM). *P < 0.05; **P < 0.01 Genistein vs. Control.

 
Ischemia was produced for 20 min by immersing the muscle preparations into fluorocarbon bubbled with a mixture of 95% N2 and 5% CO2. The isometric force decreased without a parallel reduction of peak [Ca2+]i (Figs. 1 and 2GoGo) in either control or genistein pretreated groups. After 60 min of reoxygenation, postischemic depression of myocardial function was found in all muscle preparations. Pretreatment with genistein resulted in partial reversion of postischemic depressed myocardial function in rat papillary muscles. When switching back to physiological salt solution, the isometric contractility and [Ca2+]i availability promptly recovered to near baseline values (data not shown) and these phenomena are consistent with our previous findings (16, 17).



View larger version (16K):
[in this window]
[in a new window]
 
Figure 2. Aequorin light signal and isometric contraction from representative rat papillary muscles without genistein (A) and in the presence of genistein (B) during fluorocarbon simulated ischemia-reoxygenation cycle. Upper trace, aequorin light signal; Lower trace, isometric contraction.

 
Effect of Genistein on Myofilament Responsiveness to Ca2+.
Changes in the force-peak [Ca2+]i do not accurately reflect myofilament responsiveness to calcium (13, 14). We used force-[Ca2+]i relations recorded during the steady-state condition of tetanus as an index of the sensitivity of the myofilaments to Ca2+. Figure 3Go illustrates the effect of increasing [Ca2+]o on tetanic force and Ca2+ transients in muscle preparations pretreated without genistein (Fig. 3AGo) or with genistein (Fig. 3BGo). Genistein pretreatment significantly increase sensitivity of the myofilament to Ca2+ compared with that in papillary muscles without genistein. Developed force and steady-state levels of [Ca2+]i with tetanus as a graded increase of [Ca2+]o are presented in Figure 4Go. Tetanic force was presented at 2.0, 4.0, and 8.0 mM of [Ca2+]o due to no further increase in tetanic force at higher [Ca2+]o. The force-[Ca2+]i curve of the control group was shifted to the right, whereas the force-peak [Ca2+]i curve was shifted to the left in genistein-pretreated papillary muscles. Steady-state force-peak [Ca2+]i curves for the three groups (Fig. 3Go) were fitted to the Hill equation. Maximum muscle developed tension was calculated as 12.6 ± 1.3 mN/mm2 in the normal group, 9.8 ± 0.9 mN/mm2 in the control group, and 14.7 ± 1.5 mN/mm2 in the genistein-treated group. Half-maximal [Ca2+]50 was calculated as 0.59 ± 0.02 µM in the normal group, 0.68 ± 0.04 µM in the control group, and 0.54 ± 0.01 µM in the genistein-treated group. The Hill coefficient was calculated as 7.0 ± 1.3 in the normal group, 7.9 ± 1.4 in the control group, and 6.7 ± 1.0 in the genistein-treated group.



View larger version (12K):
[in this window]
[in a new window]
 
Figure 3. Representative examples of aequorin light signal and isometric contraction during tetanic stimulation from rat postischemic papillary muscle without genistein (A) and postischemic papillary muscle in the presence of genistein (2 µM; B). Tetanus was elicited in the presence of 0.2 µM ryanodine and 2.0, 4.0, and 8.0 mM extracellular Ca2+. Tetanic stimulation was continued for 5 s because longer tetani might cause damage to the muscle and would increase aequorin consumption. Measurements were made at the end of the 5-s tetanus. Upper trace, aequorin light signal; Lower trace, isometric contraction.

 


View larger version (15K):
[in this window]
[in a new window]
 
Figure 4. Graph showing force-[Ca2+]i relation as recorded in tetanized papillary muscles isolated from adult Wistar rats. Normal, rat papillary muscles without ischemia (n = 8); Control, postischemic rat papillary muscles without genistein (n = 7); Genistein, postischemic rat papillary muscles in the presence of genistein (2 µM; n = 8). Peak tetanic isometric force is plotted against the value of intracellular Ca2+ during the tetanic plateau phase of aequorin light signal. Tetanus was elicited in the presence of 0.2 µM ryanodine and 1.0, 2.0, 4.0, 8.0, and 12.0 mM extracellular Ca2+.

 
Effect of Genistein on Protein Levels of TnI.
After the ischemia-reoxygenation cycle in fluorocarbon immersion, protein levels of TnI were measured in nonischemic papillary muscles and postischemic muscle preparations (five of each) from control and genistein-pretreated groups. Samples of postischemic papillary muscles were obtained after 60 min of reoxygenation in fluorocarbon. TnI protein immunoreactivity was decreased in control papillary muscles after ischemia compared with muscles in the presence of genistein (Fig. 5Go). The representative Western blots of TnI and immunoreactivity of TnI protein normalized to cyclophilin A in nonischemic papillary muscles, control, and genistein-pretreated groups are presented in Figure 5Go.



View larger version (15K):
[in this window]
[in a new window]
 
Figure 5. Protein expression of TnI in rat papillary muscles (n = 5) at the phase of postischemia was assessed by the Western blot (A) and densitometric analysis of TnI/Cyclophilin A (B). Normal, rat papillary muscles without ischemia; Control, rat postischemic papillary muscle without genistein; Genistein, rat postischemic papillary muscle in the presence of genistein (2 µM). **P < 0.01 vs. Normal; #P < 0.05 vs. Genistein.

 

    Discussion
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
In the present study, we demonstrated that genistein, a tyrosine kinase inhibitor, attenuated the depressed postischemic myocardial function in isolated papillary muscles. This beneficial effect on the ischemia-reperfusion cycle was associated with an increase in the Ca2+ sensitivity of the myofilaments.

The simulated ischemia model, which has been successfully used in our laboratory (1517), was produced by immersing the papillary muscle into hypoxic fluorocarbon due to the nonpolar structure of the fluorocarbon. We found that a decrease in developed tension in postischemic papillary muscles compared with controls was similar to a reduction in developed pressure in isolated stunned perfused hearts (2, 18). Thus, the use of isolated papillary muscles in the fluorocarbon-simulated ischemia model offers a novel and useful approach to investigate excitation-contraction coupling in postischemic myocardium (1517).

It is widely accepted that postischemic reperfusion injury causes cardiac dysfunction, known as stunning (1921). Although there is a general consensus that free radicals (22), damage of extracellular collagen matrix (23), and impaired myocardial energy production and use (24) are related to postischemic myocardial dysfunction, the precise mechanism is still controversial. The basis for depressed postischemic myocardial function may be related to a reduction of the contractile machinery responsiveness to Ca2+. Reported data from our laboratory (1, 18) and others (2527) have shown that myocardial stunning is at least partially due to a decrease in myofilament Ca2+ sensitivity. In the present study, we demonstrated that both myocardial contractility and Ca2+ sensitivity of myofilaments were reduced in postischemic cardiac muscle. The mechanism underlying the decreased Ca2+ responsiveness remains unknown at present.

In the present study, the alteration of TnI on the immunoblots could reflect loss of the TnI protein, partial proteolysis of the TnI, or changes in the TnI phosphorylation. Reported studies by Marban’s group (28, 29) suggested that postischemic stunning is associated with catabolism of TnI. Previous experiments indicated that phosphorylation of TnI by a cAMP-dependent protein kinase or phosphorylase kinase can decrease Ca2+ sensitivity (30). With isolated rat heart myofibrils, Wattanapermpool et al. (31) demonstrated a significant role for TnI in mediating the decrease in myofilament Ca2+ sensitivity associated with PKA-dependent phosphorylation. Densitometric analysis of myofibrillar proteins found a new protein band appearing in rat myofibrils after complete global ischemia (9). 32P-ATP autoradiogram showed that this new band is a phosphorylated TnI fragment induced by cAMP-dependent protein kinase. Strang et al. (8) also showed that both isoproterenol and PKA treatment in rat cardiac myocytes reduced the Ca2+ sensitivity during isometric contraction. It has been accepted that ischemia can produce high concentrations of catecholamines in the myocardium due to exocytotic and nonexocytotic release from adrenergic nerve endings, and impaired reuptake mechanisms (3234). Reoxygenation injury may also occur after a sudden transmembrane Ca2+ influx mediated via increased catecholamine release (35). Stimulation of {alpha}-adrenoreceptors (7, 36) and ß-adrenoreceptors (30) by an increased concentration of catecholamines during the period of ischemia-reperfusion activates the ERK cascade (the common pathway of activated protein kinases) (37). Activated ERKs in cardiac myocytes by ß-adrenoreceptor agonists, including isoproterenol, have been demonstrated by Bogoyevich (37) and Yamazaki et al. (11). A previous study (23) demonstrated that tyrosine kinases are responsible for activation of ERKs by isoproterenol and found that activation was suppressed completely when cardiomyocytes were pretreated with a broad-spectrum tyrosine kinase inhibitor, genistein. This suggests that the tyrosine kinase is involved in isoproterenol-induced activation of ERKs in cardiac myocytes.

The present findings indicate that genistein ameliorated postischemic dysfunction by enhancing the myofilament sensitivity to Ca2+. The increase of myofilament Ca2+ sensitivity by additional genistein might result from diminished phosphorylation of TnI, which is reflected by partially restoring the TnI protein levels in postischemic papillary muscles. Although studies, both previous (38) and more recent (39), demonstrated that exceeding 0.2 mm in muscle preparation diameter causes core hypoxia, the data presented here are comparable because all results were collected under the same experimental conditions in both control and genistein-treated groups. The present study was conducted at a low stimulating frequency and a 30°C temperature. Additional experiments are required to investigate the phosphorylated status of TnI during the ischemia-reperfusion sequence under physiological conditions.


    Footnotes
 
1 This work was supported in part by the National Heart, Lung, and Blood Institute (grants HL-3117 and R01 DA 11726 to J.P.M.). Back

2 To whom requests for reprints should be addressed at Cardiovascular Division, Department of Medicine, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215. E-mail: jmorgan{at}caregroup.harvard.edu Back


    References
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 

  1. Carrozza JP Jr., Bentivegna LA, Williams CP, Kuntz RE, Grossman W, Morgan JP. Decreased myofilament responsiveness in myocardial stunning follows transient calcium overload during ischemia and reperfusion. Circ Res 71:1334–1340, 1992.[Abstract/Free Full Text]
  2. Kihara Y, Grossman W, Morgan JP. Direct measurement of changes in intracellular calcium transients during hypoxia, ischemia, and reperfusion of the intact mammalian heart. Circ Res 65:1029–1044, 1989.[Abstract/Free Full Text]
  3. Kusuoka H, Marban E. Cellular mechanisms of myocardial stunning. Annu Res Physiol 54:243–256, 1992.
  4. Kusuoka H, Porterfield JK, Weisman HF, Weisfeldt ML, Marban E. Pathophysiology and pathogenesis of stunned myocardium: Depressed Ca2+ activation of contraction as a consequence of reperfusion-induced cellular calcium overload in ferret hearts. J Clin Invest 79:950–960, 1987.
  5. McDonough JL, Arrell DK, Van Eyk JE. Troponin I degradation and covalent complex formation accompanies myocardial ischemia/reperfusion injury. Circ Res 84:9–20, 1999.[Abstract/Free Full Text]
  6. Huang XP, Pi YQ, Lee KJ, Henkel AS, Gregg RG, Powers PA, Walker JW. Cardiac troponin I gene knockout: a mouse model of myocardial troponin I deficiency. Circ Res 84:1–8, 1999.[Abstract/Free Full Text]
  7. Karliner JS, Kagiya T, Simpson PC. Effects of pertussis toxin on {alpha}1-agonist-mediated phosphotidylinositide turnover and myocardial cell hypertrophy in neonatal rat ventricular myocytes. Experientia 46:81–84, 1990.[Medline]
  8. Strang KT, Sweitzer NK, Greaser ML, Moss RL. ß-Adrenergic receptor stimulation increases unloaded shortening velocity of skinned single ventricular myocytes from rats. Circ Res 74:542–549, 1994.[Abstract/Free Full Text]
  9. Noland TA Jr., Kuo JF. Protein kinase C phosphorylation of cardiac troponin I and troponin T inhibits Ca2+-stimulated MgATPase activity in reconstituted actomyosin and isolated myofibrils, and decreases actin-myosin interactions. J Mol Cell Cardiol 25:53–65, 1993.[Medline]
  10. Westfall MV, Solaro RJ. Alterations in myofibrillar function and protein profiles after complete global ischemia in rat hearts. Circ Res 70:302–313, 1992.[Abstract/Free Full Text]
  11. Yamazaki T, Komuro I, Zou Y, Kudoh S, Shiojima I, Hiroi Y, Mizuno T, Aikawa R, Takano H, Yazaki Y. Norepinephrine induces the raf-1 kinase/mitogen-activated protein kinase cascade through both {alpha}1- and ß-adrenoceptors. Circulation 95:1260–1268, 1997.[Abstract/Free Full Text]
  12. Kihara Y, Morgan JP. A comparative study of three methods for intracellular loading of the calcium indicator aequorin in ferret papillary muscle. Biochem Biophys Res Commun 162:402–407, 1989.[Medline]
  13. Litwin SE, Morgan JP. Captopril enhances intracellular calcium handling and ß-adrenergic responsiveness of myocardium from rats with postinfarction failure. Circ Res 71:797–807, 1992.[Abstract/Free Full Text]
  14. Marban E, Kusuoka H, Yue DT, Weisfeldt JL, Wier WG. Maximal Ca2+-activated force elicited by tetanization of ferret papillary muscle and whole heart: mechanism and characteristics of steady contractile activation in intact myocardium. Circ Res 59:262–269, 1986.[Abstract/Free Full Text]
  15. Bing OHL, Kihara Y, Brooks WW, Conrad CH, Morgan JP. Fluorocarbon stimulation of myocardial ischemia and reperfusion: studies of relationships between force and intracellular calcium. Cardiovasc Res 27:1863–1868, 1993.[Abstract/Free Full Text]
  16. Min JY, Hampton TG, Wang JF, DeAngelis J, Morgan JP. Depressed tolerance to fluorocarbon-simulated ischemia in failing rat myocardium due to impaired intracellular Ca2+ modulation. Am J Physiol 278:H1446–H1456, 2000.[Abstract/Free Full Text]
  17. Min JY, Ding B, Wang JF, Sullivan MF, Morgan JP. Metoprolol attenuates postischemic depressed myocardial function in papillary muscles isolated from normal and postinfarction rat hearts. Eur J Pharmacol 422:115–125, 2001.[Medline]
  18. Meissner A, Morgan JP. Contractile dysfunction and abnormal Ca2+ modulation during postischemic reperfusion in rat heart. Am J Physiol 268:H100–H111, 1995.[Abstract/Free Full Text]
  19. Bolli R. Mechanism of myocardial "stunning." Circulation 80:723– 738, 1990.
  20. Braunwald E, Kloner RA. The stunned myocardium: prolonged postischemic ventricular dysfunction. Circulation 66:1146–1149, 1982.[Abstract/Free Full Text]
  21. Marban E. Myocardial stunning and hibernation: the physiology behind the colloquialisms. Circulation 83:681–683, 1991.[Free Full Text]
  22. Sekili S, McCay PB, Li XY, Zughaib M, Sun JZ, Tang L, Thornby JI, Bolli R. Direct evidence that the hydroxyl radical plays a pathogenetic role in myocardial "stunning" in the conscious dog and demonstration that stunning can be markedly attenuated without subsequent adverse effects. Circ Res 73:705–723, 1993.[Abstract/Free Full Text]
  23. Zhao MJ, Zhang H, Robinson TF, Factor SM, Sonnenblick EH, Eng C. Profound structural alterations of the extracellular collagen matrix in postischemic dysfunction ("stunned") but viable myocardium. J Am Coll Cardiol 10:1322–1334, 1987.[Abstract]
  24. Reimer KA, Hill ML, Jennings RB. Prolonged depletion of ATP and of the adenine nucleotide pool due to delayed resynthesis of adenine nucleotides following reversible myocardial ischemic injury in dogs. J Mol Cell Cardiol 13:229–239, 1981.[Medline]
  25. Gao WD, Atar D, Backx PH, Marban E. Relationship between intracellular calcium and contractile force in stunned myocardium: direct evidence for decreased myofilament Ca2+ responsiveness and altered diastolic function in intact ventricular muscle. Circ Res 76:1036–1048, 1995.[Abstract/Free Full Text]
  26. Hofmann PA, Miller WP, Moss RL. Altered calcium sensitivity of ischemic tension in myocyte-sized preparations of porcine postischemic stunned myocardium. Circ Res 72:50–56, 1993.[Abstract/Free Full Text]
  27. Kusuoka H, Koretsune Y, Chacko VP, Weifeldt ML, Marban E. Excitation-contraction coupling in postischemic myocardium: does failure of activator Ca2+ transients underlie "stunning"? Circ Res 66: 1268–1276, 1990.[Abstract/Free Full Text]
  28. Gao WD, Atar D, Liu Y, Perez NG, Murphy AM, Marban E. Role of troponin I proteolysis in the pathogenesis of stunned myocardium. Circ Res 80:393–399, 1997.
  29. Murphy AM, Kogler H, Georgakopoulos D, McDonough JL, Kass DA, Van Eyk JE, Marban E. Transgenic mouse model of stunned myocardium. Science 287:488–491, 2000.[Abstract/Free Full Text]
  30. Sexl V, Mancusi G, Holler C, Gloria-Maercker E, Schutz W, Freissmuth M. Stimulation of the mitogen-activated protein kinase via the A2A-adenosine receptor in primary human endothelial cells. J Biol Chem 272:5792–5799, 1997.[Abstract/Free Full Text]
  31. Wattanapermpool J, Guo X, Solaro RJ. The unique amino-terminal peptide of cardiac troponin I regulates myofibrillar activity only when it is phosphorylated. J Mol Cell Cardiol 27:1383–1391, 1995.[Medline]
  32. Dart AM, Schoming A, Dietz R, Mayer E, Kuber W. Release of endogenous catecholamines in the ischemic myocardium of the rat. Part B: Effect of sympathetic nerve stimulation. Circ Res 55:702–706, 1984.[Abstract/Free Full Text]
  33. Dart AM, Riemersma RA. Neurally mediated and spontaneous release of noradrenaline in the ischemic and reperfused rat heart. J Cardiovasc Pharmacol 7(Suppl 5):S45–S49, 1985.
  34. Schomig A, Dart AM, Dietz R, Mayer E, Kubler W. Release of endogenous catecholamines in the ischemic myocardium of the rat. Part A: locally mediated release. Circ Res 55:689–701, 1984.[Abstract/Free Full Text]
  35. Harding DP, Pool-Wilson PA. Calcium exchange in rabbit myocardium during and after hypoxia: effect of temperature and substrate. Cardiovasc Res 14:435–445, 1980.[Medline]
  36. Terzic A, Puceat M, Vassort G, Vogel SM. Cardiac {alpha}1-adrenoceptors: an overview. Pharmacol Rev 45:147–175, 1993.[Medline]
  37. Bogoyevich MA, Andersson MB, Gillespie-Brown J, Clerk A, Glennon PE, Fuller SJ, Sugden PH. Adrenergic receptor stimulation of the mitogen-activated protein kinase cascade and cardiac hypertrophy. Biochem J 314:115–121, 1996.
  38. Schouten VJA, ter Keurs HEDJ. The force-frequency relationship in rat myocardium: the influence of muscle dimensions. Plugers Arch 407:14–17, 1986.[Medline]
  39. Janssen PML, Stull LB, Marban E. Myofilament properties comprise the rate-limiting step for cardiac relaxation at body temperature in the rat. Am J Physiol 282:H499–H507, 2002.[Abstract/Free Full Text]
Received for publication November 1, 2001. Accepted for publication May 1, 2002.





This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Min, J.-Y.
Right arrow Articles by Morgan, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Min, J.-Y.
Right arrow Articles by Morgan, J. P.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS